Evidence map›Paper›PMID 42384233›Full record

ArticleJournal of neurology2026

Genome-wide spectrum of coding DNA variations in Indian patients with amyotrophic lateral sclerosis.

Ananthapadmanabha Kotambail, Gautham Arunachal, Muddasu Suhasini Keerthipriya, R Mahima, Ramya Sukrutha, M B Ramyashree, Madhusudhan Deekshitha, Bhoomika M Rao, Purbasha Biswas, Kiran Polavarapu and 15 more

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Ananthapadmanabha Kotambail *Department of Neurology, National Institute of Mental Health and Neuro Sciences (NIMHANS), Bengaluru, Karnataka, India.
Gautham Arunachal *Department of Human Genetics, National Institute of Mental Health and Neuro Sciences (NIMHANS), Bengaluru, Karnataka, India.
Muddasu Suhasini KeerthipriyaDepartment of Neurology, National Institute of Mental Health and Neuro Sciences (NIMHANS), Bengaluru, Karnataka, India.
R MahimaDepartment of Human Genetics, National Institute of Mental Health and Neuro Sciences (NIMHANS), Bengaluru, Karnataka, India.
Ramya SukruthaDepartment of Human Genetics, National Institute of Mental Health and Neuro Sciences (NIMHANS), Bengaluru, Karnataka, India.
M B RamyashreeDepartment of Human Genetics, National Institute of Mental Health and Neuro Sciences (NIMHANS), Bengaluru, Karnataka, India.
Madhusudhan DeekshithaDepartment of Human Genetics, National Institute of Mental Health and Neuro Sciences (NIMHANS), Bengaluru, Karnataka, India.
Bhoomika M RaoDepartment of Human Genetics, National Institute of Mental Health and Neuro Sciences (NIMHANS), Bengaluru, Karnataka, India.
Purbasha BiswasDepartment of Neurology, National Institute of Mental Health and Neuro Sciences (NIMHANS), Bengaluru, Karnataka, India.
Kiran PolavarapuChildren's Hospital of Eastern Ontario (CHEO) Research Institute, Ottawa, ON, Canada.
Veeramani Preethish-KumarNeurofoundation, Salem, Tamil Nadu, India.
Pradeep ReddySUNY Upstate Medical University, Syracuse, NY, USA.
Olivia GrayVariant Bio Inc, Seattle, USA.
Kaja A WasikVariant Bio Inc, Seattle, USA.
Anne-Katrin EmdeVariant Bio Inc, Seattle, USA.
Sanjana AngadiDepartment of Neurology, National Institute of Mental Health and Neuro Sciences (NIMHANS), Bengaluru, Karnataka, India.
Bhaswar BhattacharyaDepartment of Neurology, National Institute of Mental Health and Neuro Sciences (NIMHANS), Bengaluru, Karnataka, India.
Marsha ZachariaDepartment of Neurology, National Institute of Mental Health and Neuro Sciences (NIMHANS), Bengaluru, Karnataka, India.
K V JeevithaDepartment of Neurology, National Institute of Mental Health and Neuro Sciences (NIMHANS), Bengaluru, Karnataka, India.
Koneti Deepak KumarDepartment of Neurology, National Institute of Mental Health and Neuro Sciences (NIMHANS), Bengaluru, Karnataka, India.
Naveen H MasaraddiDepartment of Neurology, National Institute of Mental Health and Neuro Sciences (NIMHANS), Bengaluru, Karnataka, India.
Saraswati NashiDepartment of Neurology, National Institute of Mental Health and Neuro Sciences (NIMHANS), Bengaluru, Karnataka, India.
G K ChetanDepartment of Human Genetics, National Institute of Mental Health and Neuro Sciences (NIMHANS), Bengaluru, Karnataka, India.
Seena VengalilDepartment of Neurology, National Institute of Mental Health and Neuro Sciences (NIMHANS), Bengaluru, Karnataka, India.
Atchayaram NaliniDepartment of Neurology, National Institute of Mental Health and Neuro Sciences (NIMHANS), Bengaluru, Karnataka, India. nalini@nimhans.ac.in.ORCID http://orcid.org/0000-0001-9791-3639

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease with limited therapies, emphasizing the need for deeper understanding of disease pathogenesis. While more than 40 ALS-associated genes have been identified, their contribution varies significantly across populations and the data from the Indian population remains scarce. We aimed to comprehensively characterize the spectrum of coding DNA variations in ALS-associated genes and identify novel genetic contributors in an Indian cohort. Whole-exome sequencing on 761 ALS patients and 917 in-house healthy controls and repeat-primed PCR for expansions (C9orf72, ATXN2, NOTCH2NLC, NOP56) were performed. Variants were classified using ACMG guidelines, and rare variant association testing was conducted. Overall diagnostic yield was 15.90%, with pathogenic/likely pathogenic variants. Familial ALS showed higher diagnostic yield (36.95%) than sporadic ALS (12.96%). SOD1 dominated familial cases (53.85%), while OPTN, SOD1 and FIG4 were prevalent in sporadic cases. Homozygous SOD1 variants in six patients correlated with juvenile/young onset (< 30 years). C9orf72 expansions (4%) and ATXN2 repeats (1.7%) were identified at frequencies comparable with Asian cohorts. Rare variant analysis identified JAK2 as a novel genome-wide significant signal (FDR = 3.5 × 10

Indexed as

Amyotrophic Lateral SclerosisAdultAgedAtaxin-2C9orf72 ProteinCell Cycle ProteinsExome SequencingFemaleGenetic Predisposition to DiseaseGenetic VariationGenome-Wide Association StudyHumansIndiaJanus Kinase 2MaleMembrane Transport ProteinsAtaxin-2ATXN2 protein, humanC9orf72 ProteinC9orf72 protein, humanCell Cycle ProteinsJAK2 protein, humanJanus Kinase 2Membrane Transport ProteinsOPTN protein, humanSOD1 protein, humanSuperoxide Dismutase-1Transcription Factor TFIIIAAmyotrophic lateral sclerosisExome sequencingGenetic variationNeurodegenerative diseaseSOD1

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.